Background
Methods
Study design
Study population
Sampling procedures
Data collection
Questionnaire design
Definitions
Data analysis
Results
Respondent and practice characteristics
Overall | |||
---|---|---|---|
Number (%) | 95% CI | ||
1a: Respondent characteristics | |||
Position | General Practitioner (GP) | 165 (39.9) | 35.3–44.6 |
Nurse | 202 (48.8) | 44.0–53.6 | |
Practice Manager | 29 (7.0) | 4.9–9.9 | |
Other clinical | 6 (1.4) | 0.7–3.1 | |
Other non-clinical | 7 (1.7) | 0.8–3.4 | |
Not stated | 5 (1.2) | 0.5–2.8 | |
Total responses | 414 | ||
Frequency of seeing migrant patients | Frequently | 108 (34.1) | 29.1–39.4 |
Sometimes | 103 (32.5) | 27.6–37.8 | |
Rarely | 106 (33.4) | 28.5–38.8 | |
Total responses | 317 | ||
1b: Practice characteristics | |||
Location | East of England | 36 (8.7) | 6.3–11.8 |
London | 63 (15.2) | 12.1–19.0 | |
Midlands | 86 (20.8) | 17.1–24.9 | |
North East | 23 (5.6) | 3.7–8.2 | |
North West | 60 (14.5) | 11.4–18.2 | |
South East | 65 (15.7) | 12.5–19.5 | |
South West | 30 (7.2) | 5.1–10.2 | |
Yorkshire & the Humber | 51 (12.3) | 9.5–15.8 | |
Total responses | 414 | ||
Size of practice | Small (0–5279 patients) | 39 (25.8) | 19.5–33.3 |
Medium (5280–9299 patients) | 42 (27.8) | 21.3–35.4 | |
Large (> = 9300 patients) | 70 (46.4) | 38.6–54.3 | |
Total responses | 151 | ||
Proportion of practice population that are new migrants | Low (0–9%) | 40 (50.6) | 39.8–61.4 |
Medium (10–24% patients) | 25 (31.6) | 22.4–42.5 | |
High (25–49% patients) | 4 (5.1) | 2.0–12.3 | |
Very high (50–100% patients) | 10 (12.7) | 7.0–21.8 | |
Total responses | 79 | ||
Proportion of practice population that are asylum seekers/refugees | Low (0–9%) | 57 (76.0) | 65.2–84.2 |
Medium (10–24% patients) | 7 (9.3) | 4.6–18.0 | |
High (25–49% patients) | 3 (4.0) | 1.4–11.1 | |
Very high (50–100% patients) | 8 (10.7) | 5.5–19.7 | |
Total responses | 75 |
Professional knowledge and practice
Issues considered for newly registering patients who are migrants
Question | Overall - GPs and Nurses Number (%, 95CI) | GPs Number (%, 95CI) | Nurses Number (%, 95CI) | P (GPs vs nurses) | ||
---|---|---|---|---|---|---|
Which issues do you address when speaking to new migrant patients? | Vaccination history | All new migrants | 167 (58.2, 52.4–63.7) | 58 (41.7, 33.9–50.0) | 109 (73.6, 66.0–80.1) | < 0.0001 |
Asylum seekers / refugees only | 9 (3.1, 1.7–5.9) | 4 (2.9, 1.1–7.2) | 5 (3.4, 1.5–7.7) | |||
Never considered | 14 (4.9, 2.9–8.0) | 12 (8.6, 5.0–14.5) | 2 (1.4, 0.4–4.8) | |||
Situation specific | 97 (33.8, 28.6–39.5) | 65 (46.8, 38.7–55.0) | 32 (21.6, 15.8–28.9) | |||
Total | 287 | 139 | 148 | |||
HIV risk assessment | All new migrants | 86 (30.0, 25.0–35.5) | 41 (29.5, 22.5–37.5) | 45 (30.4, 23.6–38.2) | 0.867 | |
Asylum seekers / refugees only | 7 (2.4, 1.2–4.9) | 0 (0.0, 0.0–2.7) | 7 (4.7, 2.3–9.4) | |||
Never considered | 23 (8.0, 5.4–11.7) | 8 (5.8, 2.9–10.9) | 15 (10.1, 6.2–16.0) | |||
Situation specific | 171 (59.6, 53.8–65.1) | 90 (64.7, 56.5–72.2) | 81 (54.7, 46.7–62.5) | |||
Total | 287 | 139 | 148 | |||
Hepatitis B risk assessment | All new migrants | 85 (29.6, 24.6–35.1) | 40 (28.8, 21.9–36.8) | 45 (30.4, 23.6–38.2) | 0.763 | |
Asylum seekers / refugees only | 11 (3.8, 2.2–6.7) | 1 (0.7, 0.1–4.0) | 10 (6.8, 3.7–12.0) | |||
Never considered | 24 (8.4, 5.7–12.1) | 10 (7.2, 4.0–12.7) | 14 (9.5, 5.7–15.3) | |||
Situation specific | 167 (58.2, 52.4–63.7) | 88 (63.3, 55.0–70.9) | 79 (53.4, 45.4–61.2) | |||
Total | 287 | 139 | 148 | |||
Hepatitis C risk assessment | All new migrants | 78 (27.2, 22.4–32.6) | 38 (27.3, 20.6–35.3) | 40 (27.0, 20.5–34.7) | 0.953 | |
Asylum seekers / refugees only | 12 (4.2, 2.4–7.2) | 1 (0.7, 0.1–4.0) | 11 (7.4, 4.2–12.8) | |||
Never considered | 29 (10.1, 7.1–14.1) | 10 (7.2, 4.0–12.7) | 19 (12.8, 8.4–19.2) | |||
Situation specific | 168 (58.5, 52.8–64.1) | 90 (64.7, 56.5–72.2) | 78 (52.7, 44.7–60.6) | |||
Total | 287 | 139 | 148 | |||
TB screening | All new migrants | 82 (28.6, 23.7–34.1) | 39 (28.1, 21.3–36.0) | 43 (29.1, 22.3–36.8) | 0.852 | |
Asylum seekers / refugees only | 13 (4.5, 2.7–7.6) | 4 (2.9, 1.1–7.2) | 9 (6.1, 3.2–11.2) | |||
Never considered | 34 (11.8, 8.6–16.1) | 11 (7.9, 4.5–13.6) | 23 (15.5, 10.6–22.2) | |||
Situation specific | 158 (55.1, 49.3–60.7) | 85 (61.2, 52.9–68.8) | 73 (49.3, 41.4–57.3) | |||
Total | 287 | 139 | 148 | |||
Sexual health advice and screening | All new migrants | 80 (27.9, 23.0–33.3) | 27 (19.4, 13.7–26.8) | 53 (35.8, 28.5–43.8) | 0.002 | |
Asylum seekers / refugees only | 7 (2.4, 1.2–4.9) | 0 (0.0, 0.0–2.7) | 7 (4.7, 2.3–9.4) | |||
Never considered | 18 (6.3, 4.0–9.7) | 9 (6.5, 3.4–11.8) | 9 (6.1, 3.2–11.2) | |||
Situation specific | 182 (63.4, 57.7–68.8) | 103 (74.1, 66.2–80.7) | 79 (53.4, 45.4–61.2) | |||
Total | 287 | 139 | 148 | |||
Family planning | All new migrants | 86 (30.0, 25.0–35.5) | 29 (20.9, 14.9–28.4) | 57 (38.5, 31.1–46.5) | 0.001 | |
Asylum seekers / refugees only | 7 (2.4, 1.2–4.9) | 0 (0.0, 0.0–2.7) | 7 (4.7, 2.3–9.4) | |||
Never considered | 14 (4.9, 2.9–8.0) | 7 (5.0, 2.5–10.0) | 7 (4.7, 2.3–9.4) | |||
Situation specific | 180 (62.7, 57.0–68.1) | 103 (74.1, 66.2–80.7) | 77 (52.0, 44.0–59.9) | |||
Total | 287 | 139 | 148 | |||
To the best of your knowledge, as of August 2017 which of the following services are free to all irrespective of migration status? | GP or nurse consultations in primary care | Yes | 279 (76.0, 71.4–80.1) | 130 (78.8, 71.9–84.3) | 149 (73.8, 67.3–79.3) | 0.262 |
No | 56 (15.3, 11.9–19.3) | 23 (13.9, 9.5–20.0) | 33 (16.3, 11.9–22.1) | |||
Don’t know | 32 (8.7, 6.2–12.0) | 12 (7.3, 4.2–12.3) | 20 (9.9, 6.5–14.8) | |||
Total | 367 | 165 | 202 | |||
Operations or outpatient services in secondary care | Yes | 100 (27.2, 22.9–32.0) | 36 (21.8, 16.2–28.7) | 64 (31.7, 25.7–38.4) | 0.014 | |
No | 192 (52.3, 47.2–57.4) | 98 (59.4, 51.8–66.6) | 94 (46.5, 39.8–53.4) | |||
Don’t know | 75 (20.4, 16.6–24.9) | 31 (18.8, 13.6–25.4) | 44 (21.8, 16.6–28.0) | |||
Total | 367 | 165 | 202 | |||
Family planning | Yes | 259 (70.6, 65.7–75.0) | 115 (69.7, 62.3–76.2) | 144 (71.3, 64.7–77.1) | 0.739 | |
No | 32 (8.7, 6.2–12.0) | 13 (7.9, 4.7–13.0) | 19 (9.4, 6.1–14.2) | |||
Don’t know | 76 (20.7, 16.9–25.1) | 37 (22.4, 16.7–29.4) | 39 (19.3, 14.5–25.3) | |||
Total | 367 | 165 | 202 | |||
Hepatitis B and C testing, diagnosis and management | Yes | 268 (73.0, 68.3–77.3) | 120 (72.7, 65.5–78.9) | 148 (73.3, 66.8–78.9) | 0.908 | |
No | 18 (4.9, 3.1–7.6) | 8 (4.8, 2.5–9.3) | 10 (5.0, 2.7–8.9) | |||
Don’t know | 81 (22.1, 18.1–26.6) | 37 (22.4, 16.7–29.4) | 44 (21.8, 16.6–28.0) | |||
Total | 367 | 165 | 202 | |||
Treatment of mental and physical conditions caused by torture, FGM, domestic or sexual violence | Yes | 299 (81.5, 77.2–85.1) | 125 (75.8, 68.7–81.7) | 174 (86.1, 80.7–90.2) | 0.011 | |
No | 14 (3.8, 2.3–6.3) | 12 (7.3, 4.2–12.3) | 2 (1.0, 0.3–3.5) | |||
Don’t know | 54 (14.7, 11.5–18.7) | 28 (17.0, 12.0–23.4) | 26 (12.9, 8.9–18.2) | |||
Total | 367 | 165 | 202 | |||
Communicable disease services | Yes | 305 (83.3, 79.2–86.8) | 138 (83.6, 77.2–88.5) | 167 (83.1, 77.3–87.6) | 0.806 | |
No | 8 (2.2, 1.1–4.3) | 4 (2.4, 0.9–6.1) | 4 (2.0, 0.8–5.0) | |||
Don’t know | 53 (14.5, 11.2–18.5) | 23 (13.9, 9.5–20.0) | 30 (14.9, 10.7–20.5) | |||
Total | 366 | 165 | 201 | |||
Sexually transmitted disease services | Yes | 305 (83.3, 79.2–86.8) | 135 (81.8, 75.2–87.0) | 170 (84.6, 78.9–88.9) | 0.552 | |
No | 9 (2.5, 1.3–4.6) | 5 (3.0, 1.3–6.9) | 4 (2.0, 0.8–5.0) | |||
Don’t know | 52 (14.2, 11.0–18.2) | 25 (15.2, 10.5–21.4) | 27 (13.4, 9.4–18.8) | |||
Total | 366 | 165 | 201 | |||
Emergency departments (ED) and walk in centres | Yes | 323 (88.3, 84.5–91.2) | 147 (89.1, 83.4–93.0) | 176 (87.6, 82.3–91.4) | 0.565 | |
No | 17 (4.6, 2.9–7.3) | 6 (3.6, 1.7–7.7) | 11 (5.5, 3.1–9.5) | |||
Don’t know | 26 (7.1, 4.9–10.2) | 12 (7.3, 4.2–12.3) | 14 (7.0, 4.2–11.4) | |||
Total | 366 | 165 | 201 | |||
Which of the following would be a motivation or incentive to test for BBVs? | Performance payment structure | Yes | 181 (76.1, 70.2–81.0) | 91 (74.6, 66.2–81.5) | 90 (77.6, 69.2–84.2) | 0.588 |
No | 21 (8.8, 5.8–13.1) | 15 (12.3, 7.6–19.3) | 6 (5.2, 2.4–10.8) | |||
Don’t know | 36 (15.1, 11.1–20.2) | 16 (13.1, 8.2–20.2) | 20 (17.2, 11.4–25.1) | |||
Total | 238 | 122 | 116 | |||
Local targets | Yes | 164 (69.2, 63.1–74.7) | 74 (61.2, 52.3–69.4) | 90 (77.6, 69.2–84.2) | 0.006 | |
No | 41 (17.3, 13.0–22.6) | 31 (25.6, 18.7–34.1) | 10 (8.6, 4.7–15.1) | |||
Don’t know | 32 (13.5, 9.7–18.4) | 16 (13.2, 8.3–20.4) | 16 (13.8, 8.7–21.2) | |||
Total | 237 | 121 | 116 | |||
National goals | Yes | 133 (56.1, 49.8–62.3) | 56 (46.3, 37.6–55.1) | 77 (66.4, 57.4–74.3) | 0.002 | |
No | 58 (24.5, 19.4–30.3) | 45 (37.2, 29.1–46.1) | 13 (11.2, 6.7–18.2) | |||
Don’t know | 46 (19.4, 14.9–24.9) | 20 (16.5, 11.0–24.2) | 26 (22.4, 15.8–30.8) | |||
Total | 237 | 121 | 116 | |||
CCG recommendations | Yes | 174 (73.1, 67.1–78.3) | 80 (65.6, 56.8–73.4) | 94 (81.0, 73.0–87.1) | 0.007 | |
No | 35 (14.7, 10.8–19.8) | 28 (23.0, 16.4–31.2) | 7 (6.0, 3.0–11.9) | |||
Don’t know | 29 (12.2, 8.6–17.0) | 14 (11.5, 7.0–18.3) | 15 (12.9, 8.0–20.2) | |||
Total | 238 | 122 | 116 | |||
PHE recommendations | Yes | 174 (73.1, 67.1–78.3) | 84 (68.9, 60.2–76.4) | 90 (77.6, 69.2–84.2) | 0.129 | |
No | 29 (12.2, 8.6–17.0) | 21 (17.2, 11.5–24.9) | 8 (6.9, 3.5–13.0) | |||
Don’t know | 35 (14.7, 10.8–19.8) | 17 (13.9, 8.9–21.2) | 18 (15.5, 10.0–23.2) | |||
Total | 238 | 122 | 116 | |||
NICE guidance | Yes | 161 (67.4, 61.2–73.0) | 75 (61.0, 52.1–69.1) | 86 (74.1, 65.5–81.2) | 0.03 | |
No | 39 (16.3, 12.2–21.5) | 31 (25.2, 18.4–33.5) | 8 (6.9, 3.5–13.0) | |||
Don’t know | 39 (16.3, 12.2–21.5) | 17 (13.8, 8.8–21.0) | 22 (19.0, 12.9–27.0) | |||
Total | 239 | 123 | 116 | |||
NHSE recommendations | Yes | 105 (44.5, 38.3–50.9) | 51 (42.5, 34.0–51.4) | 54 (46.6, 37.7–55.6) | 0.531 | |
No | 50 (21.2, 16.5–26.8) | 39 (32.5, 24.8–41.3) | 11 (9.5, 5.4–16.2) | |||
Don’t know | 81 (34.3, 28.6–40.6) | 30 (25.0, 18.1–33.4) | 51 (44.0, 35.3–53.0) | |||
Total | 236 | 120 | 116 | |||
CMO letter | Yes | 104 (43.7, 37.5–50.0) | 50 (41.0, 32.7–49.9) | 54 (46.6, 37.7–55.6) | 0.387 | |
No | 53 (22.3, 17.4–28.0) | 39 (32.0, 24.4–40.7) | 14 (12.1, 7.3–19.2) | |||
Don’t know | 81 (34.0, 28.3–40.3) | 33 (27.0, 20.0–35.5) | 48 (41.4, 32.8–50.5) | |||
Total | 238 | 122 | 116 | |||
What tests are requested when you test for hepatitis B? | HBsAg + HBcAb | 76 (33.9, 28.0–40.4) | 39 (35.8, 27.4–45.1) | 37 (32.2, 24.3–41.2) | 0.138 | |
HBsAg | 73 (32.6, 26.8–39.0) | 36 (33.0, 24.9–42.3) | 38 (33.0, 25.1–42.1) | |||
HBcAb | 10 (4.5, 2.4–8.0) | 5 (4.6, 2.0–10.3) | 5 (4.3, 1.9–9.8) | |||
Not known | 45 (20.1, 15.4–25.8) | 17 (15.6, 10.0–23.6) | 27 (23.5, 16.7–32.0) | |||
Other, please specify | 20 (8.9, 5.9–13.4) | 12 (11.0, 6.4–18.3) | 8 (7.0, 3.6–13.1) | |||
Total | 224 | 109 | 115 | |||
What tests are requested when you test for HCV? | Anti-HCV + HCV RNA | 32 (14.3, 10.3–19.5) | 17 (15.6, 10.0–23.6) | 15 (13.0, 8.1–20.4) | 0.007 | |
Anti-HCV | 56 (25.0, 19.8–31.1) | 36 (33.0, 24.9–42.3) | 20 (17.4, 11.5–25.3) | |||
HCV RNA | 24 (10.7, 7.3–15.4) | 11 (10.1, 5.7–17.2) | 13 (11.3, 6.7–18.4) | |||
Not known | 86 (38.4, 32.3–44.9) | 32 (29.4, 21.6–38.5) | 54 (47.0, 38.1–56.0) | |||
Other, please specify | 26 (11.6, 8.0–16.5) | 13 (11.9, 7.1–19.3) | 13 (11.3, 6.7–18.4) | |||
Total | 224 | 109 | 115 | |||
What tests are requested when you test for HIV? | Anti-HIV | 118 (52.7, 46.2–59.1) | 72 (66.1, 56.8–74.3) | 47 (40.9, 32.3–50.0) | < 0.0001 | |
Not known | 71 (31.7, 26.0–38.1) | 20 (18.3, 12.2–26.6) | 50 (43.5, 34.8–52.6) | |||
Other, please specify | 35 (15.6, 11.5–21.0) | 17 (15.6, 10.0–23.6) | 18 (15.7, 10.1–23.4) | |||
Total | 224 | 109 | 115 | |||
Do you use Dried Blood Spot (DBS) testing? | Yes | 21 (9.4, 6.2–13.9) | 6 (5.5, 2.5–11.5) | 15 (13.0, 8.1–20.4) | ||
No | 172 (76.8, 70.8–81.8) | 89 (81.7, 73.4–87.8) | 83 (72.2, 63.4–79.5) | |||
Don’t know | 31 (13.8, 9.9–19.0) | 15 (13.8, 8.5–21.5) | 16 (13.9, 8.7–21.4) | |||
Total | 224 | 109 | 115 | |||
These questions relate to diagnosed patients | Are all patients with hepatitis B referred to secondary care? | Yes | 176 (78.9, 73.1–83.8) | 99 (91.7, 84.9–95.6) | 77 (67.0, 57.9–74.9) | < 0.0001 |
No | 13 (5.8, 3.4–9.7) | 8 (7.4, 3.8–13.9) | 5 (4.3, 1.9–9.8) | |||
Don’t know | 34 (15.2, 11.1–20.5) | 1 (0.9, 0.2–5.1) | 33 (28.7, 21.2–37.5) | |||
Total | 223 | 108 | 115 | |||
Are all patients with hepatitis C referred to secondary care? | Yes | 180 (80.7, 75.0–85.4) | 102 (94.4, 88.4–97.4) | 78 (67.8, 58.8–75.7) | < 0.0001 | |
No | 9 (4.0, 2.1–7.5) | 5 (4.6, 2.0–10.4) | 4 (3.5, 1.4–8.6) | |||
Don’t know | 34 (15.2, 11.1–20.5) | 1 (0.9, 0.2–5.1) | 33 (28.7, 21.2–37.5) | |||
Total | 223 | 108 | 115 | |||
Do you receive information or check whether a patient has attended? | Yes | 123 (55.2, 48.6–61.5) | 67 (62.0, 52.6–70.6) | 56 (48.7, 39.8–57.7) | 0.045 | |
No | 37 (16.6, 12.3–22.0) | 26 (24.1, 17.0–32.9) | 11 (9.6, 5.4–16.3) | |||
Don’t know | 63 (28.3, 22.7–34.5) | 15 (13.9, 8.6–21.7) | 48 (41.7, 33.1–50.9) | |||
Total | 223 | 108 | 115 | |||
Do you follow up patients that have not attended secondary care appointments? | Yes | 104 (46.6, 40.2–53.2) | 57 (52.8, 43.4–61.9) | 47 (40.9, 32.3–50.0) | 0.075 | |
No | 51 (22.9, 17.8–28.8) | 37 (34.3, 26.0–43.6) | 14 (12.2, 7.4–19.4) | |||
Don’t know | 68 (30.5, 24.8–36.8) | 14 (13.0, 7.9–20.6) | 54 (47.0, 38.1–56.0) | |||
Total | 223 | 108 | 115 | |||
Are close contacts of HBV cases offered testing? | Yes | 161 (72.2, 66.0–77.7) | 80 (74.1, 65.1–81.4) | 81 (70.4, 61.5–78.0) | 0.544 | |
No | 13 (5.8, 3.4–9.7) | 9 (8.3, 4.4–15.1) | 4 (3.5, 1.4–8.6) | |||
Don’t know | 49 (22.0, 17.0–27.9) | 19 (17.6, 11.6–25.8) | 30 (26.1, 18.9–34.8) | |||
Total | 223 | 108 | 115 | |||
Are close contacts of HBV cases offered vaccination? | Yes | 165 (74.0, 67.9–79.3) | 79 (73.1, 64.1–80.6) | 86 (74.8, 66.1–81.8) | 0.781 | |
No | 14 (6.3, 3.8–10.3) | 9 (8.3, 4.4–15.1) | 5 (4.3, 1.9–9.8) | |||
Don’t know | 44 (19.7, 15.0–25.4) | 20 (18.5, 12.3–26.9) | 24 (20.9, 14.4–29.2) | |||
Total | 223 | 108 | 115 |
Knowledge of migrants’ entitlements to health services
Laboratory tests for BBV diagnosis
Incentives for testing
Management of patients diagnosed with hepatitis B and C
Practice policy
Practice policy for offering BBV testing to migrant patients
Question | Blood borne virus (BBV) | Total Number (%, 95CI) | P (difference between questions) | By frequency of seeing migrant patients | By practice size | |||||
---|---|---|---|---|---|---|---|---|---|---|
Frequently Number (%, 95CI) | Sometimes or rarely Number (%, 95CI) | P (frequency of seeing migrant patients) | Number (%, 95CI) | Number (%, 95CI) | Number (%, 95CI) | P (practice size) | ||||
What is your practice policy for offering blood borne virus (BBV) testing to new migrants? | Hepatitis B | HBV new vs existing migrants p = 0.045 | < 0.0001 | 0.001 | ||||||
Universal / ‘opt out’ | 46 (17.8, 13.6–23.0) | 34 (36.2, 27.2–46.2) | 13 (7.9, 4.7–13.1) | 16 (42.1, 27.9–57.8) | 6 (14.3, 6.7–27.8) | 9 (12.9, 6.9–22.7) | ||||
Ad hoc | 113 (43.8, 37.9–49.9) | 37 (39.4, 30.1–49.5) | 76 (46.3, 38.9–54.0) | 11 (28.9, 17.0–44.8) | 18 (42.9, 29.1–57.8) | 31 (44.3, 33.2–55.9) | ||||
Other | 18 (7.0, 4.5–10.8) | 5 (5.3, 2.3–11.9) | 12 (7.3, 4.2–12.4) | 4 (10.5, 4.2–24.1) | 2 (4.8, 1.3–15.8) | 6 (8.6, 4.0–17.5) | ||||
Don’t know | 81 (31.4, 26.0–37.3) | 18 (19.1, 12.5–28.3) | 63 (38.4, 31.3–46.0) | 7 (18.4, 9.2–33.4) | 16 (38.1, 25.0–53.2) | 24 (34.3, 24.2–46.0) | ||||
Total responses | 258 | 94 | 164 | 38 | 42 | 70 | ||||
Hepatitis C | HCV new vs existing migrants p = 0.041 | < 0.0001 | 0.001 | |||||||
Universal / ‘opt out’ | 44 (17.1, 13.0–22.2) | 33 (35.5, 26.5–45.6) | 12 (7.3, 4.2–12.4) | 15 (39.5, 25.6–55.3) | 6 (14.3, 6.7–27.8) | 8 (11.6, 6.0–21.2) | ||||
Ad hoc | 114 (44.4, 38.4–50.5) | 37 (39.8, 30.4–49.9) | 77 (47.0, 39.5–54.6) | 12 (31.6, 19.1–47.5) | 18 (42.9, 29.1–57.8) | 31 (44.9, 33.8–56.6) | ||||
Other | 18 (7.0, 4.5–10.8) | 5 (5.4, 2.3–12.0) | 12 (7.3, 4.2–12.4) | 4 (10.5, 4.2–24.1) | 2 (4.8, 1.3–15.8) | 6 (8.7, 4.0–17.7) | ||||
Don’t know | 81 (31.5, 26.1–37.4) | 18 (19.4, 12.6–28.5) | 63 (38.4, 31.3–46.0) | 7 (18.4, 9.2–33.4) | 16 (38.1, 25.0–53.2) | 24 (34.8, 24.6–46.6) | ||||
Total responses | 257 | 93 | 164 | 38 | 42 | 69 | ||||
HIV | HIV vs HBV, HCV for new migrants p = 0.498 HIV new vs existing migrants p = 0.048 | < 0.0001 | 0.002 | |||||||
Universal / ‘opt out’ | 54 (20.9, 16.4–26.3) | 39 (41.5, 32.1–51.6) | 16 (9.8, 6.1–15.3) | 18 (47.4, 32.5–62.7) | 7 (16.7, 8.3–30.6) | 14 (20.0, 12.3–30.8) | ||||
Ad hoc | 111 (43.0, 37.1–49.1) | 35 (37.2, 28.1–47.3) | 76 (46.3, 38.9–54.0) | 10 (26.3, 15.0–42.0) | 18 (42.9, 29.1–57.8) | 29 (41.4, 30.6–53.1) | ||||
Other | 17 (6.6, 4.2–10.3) | 5 (5.3, 2.3–11.9) | 11 (6.7, 3.8–11.6) | 4 (10.5, 4.2–24.1) | 2 (4.8, 1.3–15.8) | 5 (7.1, 3.1–15.7) | ||||
Don’t know | 76 (29.5, 24.2–35.3) | 15 (16.0, 9.9–24.7) | 61 (37.2, 30.2–44.8) | 6 (15.8, 7.4–30.4) | 15 (35.7, 23.0–50.8) | 22 (31.4, 21.8–43.0) | ||||
Total responses | 258 | 94 | 164 | 38 | 42 | 70 | ||||
What is your practice policy for offering BBV testing to existing migrants? | Hepatitis B | HIV vs HBV, HCV for existing migrants p = 0.480 | < 0.0001 | 0.001 | ||||||
Universal / ‘opt out’ | 29 (11.2, 7.9–15.7) | 21 (22.3, 15.1–31.8) | 8 (4.9, 2.5–9.3) | 11 (28.9, 17.0–44.8) | 3 (7.1, 2.5–19.0) | 3 (4.3, 1.5–11.9) | ||||
Ad hoc | 133 (51.6, 45.5–57.6) | 46 (48.9, 39.1–58.9) | 87 (53.0, 45.4–60.5) | 17 (44.7, 30.1–60.3) | 21 (50.0, 35.5–64.5) | 39 (55.7, 44.1–66.8) | ||||
Other | 25 (9.7, 6.6–13.9) | 11 (11.7, 6.7–19.8) | 14 (8.5, 5.2–13.8) | 5 (13.2, 5.8–27.3) | 4 (9.5, 3.8–22.1) | 7 (10.0, 4.9–19.2) | ||||
Don’t know | 71 (27.5, 22.4–33.3) | 16 (17.0, 10.8–25.9) | 55 (33.5, 26.8–41.1) | 5 (13.2, 5.8–27.3) | 14 (33.3, 21.0–48.4) | 21 (30.0, 20.5–41.5) | ||||
Total | 258 | 94 | 164 | 38 | 42 | 70 | ||||
Hepatitis C | < 0.0001 | < 0.0001 | ||||||||
Universal / ‘opt out’ | 27 (10.7, 7.5–15.1) | 20 (21.5, 14.4–30.9) | 7 (4.4, 2.1–8.8) | 11 (30.6, 18.0–46.9) | 2 (5.0, 1.4–16.5) | 2 (2.9, 0.8–10.0) | ||||
Ad hoc | 131 (52.0, 45.8–58.1) | 46 (49.5, 39.5–59.4) | 85 (53.5, 45.7–61.0) | 16 (44.4, 29.5–60.4) | 20 (50.0, 35.2–64.8) | 39 (56.5, 44.8–67.6) | ||||
Other | 25 (9.9, 6.8–14.2) | 11 (11.8, 6.7–19.9) | 14 (8.8, 5.3–14.2) | 5 (13.9, 6.1–28.7) | 4 (10.0, 4.0–23.1) | 7 (10.1, 5.0–19.5) | ||||
Don’t know | 69 (27.4, 22.2–33.2) | 16 (17.2, 10.9–26.1) | 53 (33.3, 26.5–41.0) | 4 (11.1, 4.4–25.3) | 14 (35.0, 22.1–50.5) | 21 (30.4, 20.8–42.1) | ||||
Total | 252 | 93 | 159 | 36 | 40 | 69 | ||||
HIV | < 0.0001 | < 0.0001 | ||||||||
Universal / ‘opt out’ | 36 (14.0, 10.3–18.7) | 24 (25.5, 17.8–35.2) | 12 (7.3, 4.2–12.4) | 14 (36.8, 23.4–52.7) | 4 (13.8, 5.5–30.6) | 5 (9.8, 4.3–21.0) | ||||
Ad hoc | 133 (51.6, 45.5–57.6) | 46 (48.9, 39.1–58.9) | 87 (53.0, 45.4–60.5) | 16 (42.1, 27.9–57.8) | 21 (72.4, 54.3–85.3) | 39 (76.5, 63.2–86.0) | ||||
Other | 25 (9.7, 6.6–13.9) | 11 (11.7, 6.7–19.8) | 14 (8.5, 5.2–13.8) | 5 (13.2, 5.8–27.3) | 4 (13.8, 5.5–30.6) | 7 (13.7, 6.8–25.7) | ||||
Don’t know | 64 (24.8, 19.9–30.4) | 13 (13.8, 8.3–22.2) | 51 (31.1, 24.5–38.5) | 3 (7.9, 2.7–20.8) | 13 (44.8, 28.4–62.5) | 19 (37.3, 25.3–51.0) | ||||
Total | 258 | 94 | 164 | 38 | 29 | 51 | ||||
How are existing migrants identified for testing? | Opportunistic during consultation | n/a | 0.052 | 0.111 | ||||||
Yes | 191 (78.9, 73.4–83.6) | 77 (85.6, 76.8–91.4) | 114 (75.0, 67.6–81.2) | 34 (89.5, 75.9–95.8) | 30 (71.4, 56.4–82.8) | 53 (75.7, 64.5–84.2) | ||||
No | 9 (3.7, 2.0–6.9) | 5 (5.6, 2.4–12.4) | 4 (2.6, 1.0–6.6) | 1 (2.6, 0.5–13.5) | 2 (4.8, 1.3–15.8) | 4 (5.7, 2.2–13.8) | ||||
Don’t know | 42 (17.4, 13.1–22.6) | 8 (8.9, 4.6–16.6) | 34 (22.4, 16.5–29.6) | 3 (7.9, 2.7–20.8) | 10 (23.8, 13.5–38.5) | 13 (18.6, 11.2–29.2) | ||||
Total | 242 | 90 | 152 | 38 | 7 | 70 | ||||
Any periodic flagging | n/a | 0.026 | 0.04 | |||||||
Yes | 33 (13.6, 9.9–18.5) | 18 (20.0, 13.0–29.4) | 15 (9.9, 6.1–15.6) | 10 (26.3, 15.0–42.0) | 4 (9.5, 3.8–22.1) | 7 (10.0, 4.9–19.2) | ||||
No/don’t know | 209 (86.4, 81.5–90.1) | 72 (80.0, 70.6–87.0) | 137 (90.1, 84.4–93.9) | 28 (73.7, 58.0–85.0) | 38 (90.5, 77.9–96.2) | 63 (90.0, 80.8–95.1) | ||||
Total | 242 | 90 | 152 | 38 | 42 | 70 |
Identification of migrant patients for BBV testing
Services offered
Question | No. (%, 95%CI) | P (between questions) | By frequency of seeing migrant patients | By practice size | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Frequently No. (%, 95%CI) | Sometimes or rarely No. (%, 95%CI) | P (frequency of seeing migrant patients) | Small No. (%, 95%CI) | Med No. (%, 95%CI) | Large No. (%, 95%CI) | P (practice size) | ||||
Services in place to facilitate blood borne virus (BBV) testing and care of migrant patients | Interpreter facilities | n/a | 0.266 | 0.568 | ||||||
Yes | 133 (87.5, 81.3-91.8) | 60 (90.9, 81.6-95.8) | 73 (84.9, 75.8-90.9) | 35 (92.1, 79.2-97.3) | 36 (87.8, 74.5-94.7) | 59 (84.3, 74.0-91.0) | ||||
No | 14 (9.2, 5.6-14.9) | 5 (7.6, 3.3-16.5) | 9 (10.5, 5.6-18.7) | 2 (5.3, 1.5-17.3) | 4 (9.8, 3.9-22.5) | 8 (11.4, 5.9-21.0) | ||||
Don’t know | 5 (3.3, 1.4-7.5) | 1 (1.5, 0.3-8.1) | 4 (4.7, 1.8-11.4) | 1 (2.6, 0.5-13.5) | 1 (2.4, 0.4-12.6) | 3 (4.3, 1.5-11.9) | ||||
Total responses | 152 | 66 | 86 | 38 | 41 | 70 | ||||
Longer appointments at registration | n/a | < 0.0001 | 0.083 | |||||||
Yes | 53 (22.0, 17.2-27.6) | 31 (34.4, 25.4-44.7) | 22 (14.6, 9.8-21.1) | 14 (36.8, 23.4-52.7) | 10 (23.8, 13.5-38.5) | 12 (17.1, 10.1-27.6) | ||||
No | 162 (67.2, 61.1-72.8) | 53 (58.9, 48.6-68.5) | 109 (72.2, 64.6-78.7) | 22 (57.9, 42.2-72.1) | 29 (69.0, 54.0-80.9) | 52 (74.3, 63.0-83.1) | ||||
Don’t know | 26 (10.8, 7.5-15.3) | 6 (6.7, 3.1-13.8) | 20 (13.2, 8.7-19.6) | 2 (5.3, 1.5-17.3) | 3 (7.1, 2.5-19.0) | 6 (8.6, 4.0-17.5) | ||||
Total responses | 241 | 90 | 151 | 38 | 42 | 70 | ||||
Specially designated clinic | n/a | < 0.0001 | 0.074 | |||||||
Yes | 23 (9.5, 6.4-13.9) | 17 (18.9, 12.1-28.2) | 6 (4.0, 1.8-8.4) | 6 (15.8, 7.4-30.4) | 1 (2.4, 0.4-12.3) | 4 (5.7, 2.2-13.8) | ||||
No | 196 (81.3, 75.9-85.7) | 69 (76.7, 66.9-84.2) | 127 (84.1, 77.4-89.1) | 30 (78.9, 63.7-88.9) | 39 (92.9, 81.0-97.5) | 61 (87.1, 77.3-93.1) | ||||
Don’t know | 22 (9.1, 6.1-13.4) | 4 (4.4, 1.7-10.9) | 18 (11.9, 7.7-18.1) | 2 (5.3, 1.5-17.3) | 2 (4.8, 1.3-15.8) | 5 (7.1, 3.1-15.7) | ||||
Total responses | 241 | 90 | 151 | 38 | 42 | 70 | ||||
Designated GP | n/a | 0.05 | 1.00 | |||||||
Yes | 21 (8.7, 5.8-13.0) | 12 (13.3, 7.8-21.9) | 9 (6.0, 3.2-10.9) | 3 (7.9, 2.7-20.8) | 3 (7.1, 2.5-19.0) | 5 (7.1, 3.1-15.7) | ||||
No | 195 (80.9, 75.5-85.4) | 71 (78.9, 69.4-86.0) | 124 (82.1, 75.2-87.4) | 32 (84.2, 69.6-92.6) | 37 (88.1, 75.0-94.8) | 61 (87.1, 77.3-93.1) | ||||
Don’t know | 25 (10.4, 7.1-14.9) | 7 (7.8, 3.8-15.2) | 18 (11.9, 7.7-18.1) | 3 (7.9, 2.7-20.8) | 2 (4.8, 1.3-15.8) | 4 (5.7, 2.2-13.8) | ||||
Total responses | 241 | 90 | 151 | 38 | 42 | 70 | ||||
Specific projects to register migrants | n/a | < 0.0001 | 0.024 | |||||||
Yes | 28 (11.6, 8.2-16.3) | 19 (21.1, 14.0-30.6) | 9 (6.0, 3.2-10.9) | 8 (21.1, 11.1-36.3) | 1 (2.4, 0.4-12.3) | 6 (8.6, 4.0-17.5) | ||||
No | 179 (74.3, 68.4-79.4) | 63 (70.0, 59.9-78.5) | 116 (76.8, 69.5-82.8) | 28 (73.7, 58.0-85.0) | 37 (88.1, 75.0-94.8) | 57 (81.4, 70.8-88.8) | ||||
Don’t know | 34 (14.1, 10.3-19.1) | 8 (8.9, 4.6-16.6) | 26 (17.2, 12.0-24.0) | 2 (5.3, 1.5-17.3) | 4 (9.5, 3.8-22.1) | 7 (10.0, 4.9-19.2) | ||||
Total responses | 241 | 90 | 151 | 38 | 42 | 70 | ||||
Outreach facilities | n/a | 0.029 | 0.019 | |||||||
Yes | 20 (8.3, 5.4-12.5) | 12 (13.3, 7.8-21.9) | 8 (5.3, 2.7-10.1) | 7 (18.4, 9.2-33.4) | 3 (7.1, 2.5-19.0) | 2 (2.9, 0.8-9.8) | ||||
No | 190 (78.8, 73.2-83.5) | 73 (81.1, 71.8-87.9) | 117 (77.5, 70.2-83.4) | 27 (71.1, 55.2-83.0) | 36 (85.7, 72.2-93.3) | 63 (90.0, 80.8-95.1) | ||||
Don’t know | 31 (12.9, 9.2-17.7) | 5 (5.6, 2.4-12.4) | 26 (17.2, 12.0-24.0) | 4 (10.5, 4.2-24.1) | 3 (7.1, 2.5-19.0) | 5 (7.1, 3.1-15.7) | ||||
Total responses | 241 | 90 | 151 | 38 | 42 | 70 | ||||
Outreach services specifically for migrants | n/a | 0.888 | 0.048 | |||||||
Yes | 11 (7.2, 4.1-12.5) | 5 (7.6, 3.3-16.5) | 6 (7.0, 3.2-14.4) | 6 (15.8, 7.4-30.4) | 3 (7.3, 2.5-19.4) | 2 (2.9, 0.8-9.8) | ||||
No | 111 (73.0, 65.5-79.4) | 50 (75.8, 64.2-84.5) | 61 (70.9, 60.6-79.5) | 25 (65.8, 49.9-78.8) | 31 (75.6, 60.7-86.2) | 53 (75.7, 64.5-84.2) | ||||
Don’t know | 30 (19.7, 14.2-26.8) | 11 (16.7, 9.6-27.4) | 19 (22.1, 14.6-31.9) | 7 (18.4, 9.2-33.4) | 7 (17.1, 8.5-31.3) | 15 (21.4, 13.4-32.4) | ||||
Total responses | 152 | 66 | 86 | 38 | 41 | 70 | ||||
Health support teams | n/a | 0.517 | 0.123 | |||||||
Yes | 18 (7.5, 4.8-11.5) | 8 (8.9, 4.6-16.6) | 10 (6.6, 3.6-11.8) | 5 (13.2, 5.8-27.3) | 4 (9.5, 3.8-22.1) | 2 (2.9, 0.8-9.8) | ||||
No | 184 (76.3, 70.6-81.3) | 73 (81.1, 71.8-87.9) | 111 (73.5, 66.0-79.9) | 29 (76.3, 60.8-87.0) | 35 (83.3, 69.4-91.7) | 61 (87.1, 77.3-93.1) | ||||
Don’t know | 39 (16.2, 12.1-21.4) | 9 (10.0, 5.4-17.9) | 30 (19.9, 14.3-26.9) | 4 (10.5, 4.2-24.1) | 3 (7.1, 2.5-19.0) | 7 (10.0, 4.9-19.2) | ||||
Total responses | 241 | 90 | 151 | 38 | 42 | 70 | ||||
Incentive scheme for GPs | n/a | 0.065 | 0.693 | |||||||
Yes | 11 (4.6, 2.6-8.0) | 7 (7.8, 3.8-15.2) | 4 (2.6, 1.0-6.6) | 1 (2.6, 0.5-13.5) | 3 (7.1, 2.5-19.0) | 3 (4.3, 1.5-11.9) | ||||
No | 184 (76.3, 70.6-81.3) | 71 (78.9, 69.4-86.0) | 113 (74.8, 67.4-81.1) | 32 (84.2, 69.6-92.6) | 32 (76.2, 61.5-86.5) | 56 (80.0, 69.2-87.7) | ||||
Don't know | 46 (19.1, 14.6-24.5) | 12 (13.3, 7.8-21.9) | 34 (22.5, 16.6-29.8) | 5 (13.2, 5.8-27.3) | 7 (16.7, 8.3-30.6) | 11 (15.7, 9.0-26.0) | ||||
Total responses | 241 | 90 | 151 | 38 | 42 | 70 | ||||
Routine recording of data | Ethnicity | Ethnicity vs country of birth P < 0.0001 | 0.168 | 0.939 | ||||||
Yes | 137 (90.1, 84.4-93.9) | 62 (93.9, 85.4-97.6) | 75 (87.2, 78.5-92.7) | 35 (92.1, 79.2-97.3) | 37 (90.2, 77.5-96.1) | 62 (88.6, 79.0-94.1) | ||||
No | 6 (3.9, 1.8-8.3) | 1 (1.5, 0.3-8.1) | 5 (5.8, 2.5-12.9) | 3 (7.9, 2.7-20.8) | 2 (4.9, 1.3-16.1) | 1 (1.4, 0.3-7.7) | ||||
Don't know | 9 (5.9, 3.1-10.9) | 3 (4.5, 1.6-12.5) | 6 (7.0, 3.2-14.4) | 0 (0.0, 0.0-9.2) | 2 (4.9, 1.3-16.1) | 7 (10.0, 4.9-19.2) | ||||
Total responses | 152 | 66 | 86 | 38 | 41 | 70 | ||||
Country of birth | 0.002 | 0.042 | ||||||||
Yes | 89 (58.6, 50.6-66.1) | 48 (72.7, 61.0-82.0) | 41 (47.7, 37.4-58.1) | 28 (82.4, 66.5-91.7) | 24 (66.7, 50.3-79.8) | 34 (66.7, 53.0-78.0) | ||||
No | 35 (23.0, 17.0-30.3) | 10 (15.2, 8.4-25.7) | 25 (29.1, 20.5-39.4) | 6 (17.6, 8.3-33.5) | 12 (33.3, 20.2-49.7) | 17 (33.3, 22.0-47.0) | ||||
Don't know | 28 (18.4, 13.1-25.3) | 8 (12.1, 6.3-22.1) | 20 (23.3, 15.6-33.2) | 4 (11.8, 4.7-26.6) | 5 (13.9, 6.1-28.7) | 19 (37.3, 25.3-51.0) | ||||
Total | 152 | 66 | 86 | 34 | 36 | 51 | ||||
Hepatitis diagnosis | 0.064 | 0.711 | ||||||||
Yes | 113 (74.3, 66.9-80.6) | n/a | 54 (81.8, 70.9-89.3) | 59 (68.6, 58.2-77.4) | 30 (78.9, 63.7-88.9) | 29 (70.7, 55.5-82.4) | 53 (75.7, 64.5-84.2) | |||
No | 23 (15.1, 10.3-21.7) | 7 (10.6, 5.2-20.3) | 16 (18.6, 11.8-28.1) | 6 (15.8, 7.4-30.4) | 6 (14.6, 6.9-28.4) | 10 (14.3, 7.9-24.3) | ||||
Don't know | 16 (10.5, 6.6-16.4) | 5 (7.6, 3.3-16.5) | 11 (12.8, 7.3-21.5) | 2 (5.3, 1.5-17.3) | 6 (14.6, 6.9-28.4) | 7 (10.0, 4.9-19.2) | ||||
Total responses | 152 | 66 | 86 | 38 | 41 | 70 | ||||
Hepatitis prescription | 0.842 | 0.309 | ||||||||
Yes | 82 (53.9, 46.0-61.7) | n/a | 35 (53.0, 41.2-64.6) | 47 (54.7, 44.2-64.7) | 24 (63.2, 47.3-76.6) | 24 (58.5, 43.4-72.2) | 34 (48.6, 37.2-60.0) | |||
No | 40 (26.3, 20.0-33.8) | 20 (30.3, 20.6-42.2) | 20 (23.3, 15.6-33.2) | 11 (28.9, 17.0-44.8) | 9 (22.0, 12.0-36.7) | 18 (25.7, 16.9-37.0) | ||||
Don't know | 30 (19.7, 14.2-26.8) | 11 (16.7, 9.6-27.4) | 19 (22.1, 14.6-31.9) | 3 (7.9, 2.7-20.8) | 8 (19.5, 10.2-34.0) | 18 (25.7, 16.9-37.0) | ||||
Total responses | 152 | 66 | 86 | 38 | 41 | 70 |